Are the Protective Effects of SGLT2 Inhibitors a "Class-Effect" or Are There Differences between Agents?

被引:14
|
作者
Schmidt, Darren W. [1 ]
Argyropoulos, Christos [1 ]
Singh, Namita [1 ]
机构
[1] Univ New Mexico, Sch Med, Div Nephrol, 1 Univ New Mexico,MSC04-2785, Albuquerque, NM 87131 USA
来源
KIDNEY360 | 2021年 / 2卷 / 05期
关键词
chronic kidney disease; class effects; clinical trials; heart failure; SGLT2; inhibitors; sodium glucose cotransporter two inhibitors; GLOMERULAR HYPERFILTRATION; HYPERGLYCEMIA;
D O I
10.34067/KID.0000622021
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:881 / 885
页数:5
相关论文
共 50 条
  • [21] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [22] SGLT2 inhibitors
    Dardi, I.
    Kouvatsos, T.
    Jabbour, S. A.
    BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
  • [23] SGLT2 inhibitors
    Steyn, Lynda
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
  • [24] Direct cardiac effects of SGLT2 inhibitors
    Sha Chen
    Ruben Coronel
    Markus W. Hollmann
    Nina C. Weber
    Coert J. Zuurbier
    Cardiovascular Diabetology, 21
  • [25] Direct cardiac effects of SGLT2 inhibitors
    Chen, Sha
    Coronel, Ruben
    Hollmann, Markus W.
    Weber, Nina C.
    Zuurbier, Coert J.
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [26] Renal effects of SGLT2 inhibitors: an update
    Nespoux, Josselin
    Vallon, Volker
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (02): : 190 - 198
  • [27] SGLT2 inhibitors and the kidney: Effects and mechanisms
    Tsimihodimos, V.
    Filippatos, T. D.
    Elisaf, M. S.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (06) : 1117 - 1123
  • [28] The Effects of SGLT2 Inhibitors on Lipid Metabolism
    Szekeres, Zsolt
    Toth, Kalman
    Szabados, Eszter
    METABOLITES, 2021, 11 (02) : 1 - 9
  • [29] The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors
    Dabour, Mohamed S.
    George, Mina Y.
    Daniel, Mary R.
    Blaes, Anne H.
    Zordoky, Beshay N.
    JACC: CARDIOONCOLOGY, 2024, 6 (02): : 159 - 182
  • [30] Renal and cardiac effects of SGLT2 inhibitors
    Menne J.
    Der Nephrologe, 2017, 12 (2): : 90 - 96